Franklin Resources
TARS icon

Franklin Resources’s Tarsus Pharmaceuticals TARS Stock Holding History

Franklin Resources’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18M Sell
286,008
-47,668
-14% -$3.05M ﹤0.01% 1048
2026
Q1 		$23.4M Sell
333,676
-3,340
-1% -$233K 0.01% 926
2025
Q4 		$27.6M Buy
337,016
+314,833
+1,419% +$23.5M 0.01% 848
2025
Q3 		$1.32M Buy
22,183
+781
+4% +$38.5K ﹤0.01% 1957
2025
Q2 		$867K Buy
21,402
+750
+4% +$33.8K ﹤0.01% 2061
2025
Q1 		$1.06M Buy
20,652
+10,892
+112% +$538K ﹤0.01% 1946
2024
Q4 		$540K Sell
9,760
-2,404
-20% -$109K ﹤0.01% 2250
2024
Q3 		$444K Buy
12,164
+1,033
+9% +$29K ﹤0.01% 2332
2024
Q2 		$303K Buy
+11,131
New +$374K ﹤0.01% 2429

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Franklin Resources's TARS Position: Q2 2026 in Review

Franklin Resources reduced its Tarsus Pharmaceuticals (TARS) stake by 14% in Q2 2026, selling an estimated $3.05M and leaving 286,008 shares worth $18M. The position accounts for ﹤0.01% of the portfolio, ranked #1048.

Franklin Resources first reported a position in TARS in Q2 2024 and has held it in 9 quarters since. The position peaked at $27.6M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Franklin Resources held 286,008 shares of Tarsus Pharmaceuticals worth $18M as of Q2 2026.
  • Franklin Resources sold 47,668 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $3.05M.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1048 holding.
  • Franklin Resources first reported a position in Tarsus Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Franklin Resources's Tarsus Pharmaceuticals position peaked at $27.6M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.